advertisement

Topcon

Fortino I 21

Showing records 1 to 21 | Display all abstracts from Fortino I

127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Quaranta L
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Novella A
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Galbussera AA
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Quaranta L
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Galbussera AA
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Pasina L
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Tettamanti M; Novella A
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Galbussera AA; Galbussera AA
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Pasina L
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Tettamanti M; Fortino I
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Fortino I
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Fortino I
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Fortino I
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Leoni O
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Leoni O
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Leoni O
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Leoni O; Oddone F
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Weinreb RN
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Giammaria S
Advances in Therapy 2025; 42: 4403-4417
127629 Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Nobili A
Advances in Therapy 2025; 42: 3743-3761
127164 Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Kużniak M; Weinreb RN; Nobili A
Advances in Therapy 2025; 42: 4403-4417

Issue 25-3

Change Issue


advertisement

WGA Rescources